Notice type: 3rd Party Publications
This notice is to inform healthcare professionals about an update to prescribing information. In the case of medical termination of intrauterine pregnancy, a dose adjustment to a higher dose (600 mg) is advised where the patient is being treated concomitantly with CYP3A4 inducers.
Please see the document linked below for further information.